Peptides for Focus
The peptides people most often research for focus, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.
- Peptides listed
- 2
- With human trials
- 2
- FDA approved (any use)
- 0
- SemaxACTH(4-10) analogHuman RCT evidence, 4 of 4Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2018, PMID 29798983Human2Animal1Summarised8PCAC voted 8–5 for 503A (Jul 2026)For focusOverview
- SelankTuftsin analogHuman RCT evidence, 4 of 4Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2014, PMID 25176261Human1Animal0Summarised6Not FDA approved · research chemicalFor focusOverview
What this list does not show
Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.
Search interest is not evidence
This list follows what people search for and discuss. It says nothing about how well any peptide works.Animal results may not carry over
Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.Approval covers specific uses
An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.Combinations are a separate question
Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.What problems with focus can mean
MedlinePlus notes that people with the inattentive form of ADHD have trouble paying attention and are easily distracted, one medical meaning of poor focus.[3]
MedlinePlus says anxiety may give you a boost of energy or help you focus.[4]
Focus data are thin and come from sleep or rat studies
Semax has 2 human-only and 1 animal paper on focus and Selank has 1 human-only paper, with no randomised trial for either.
Calculated from source our PubMed count ledger ledger (PubMed title/abstract counts, 2026-10-02); semax human only 2, animal only 1, rct 0; selank human only 1, animal only 0, rct 0. Formula: Counts copied from each peptide ledger: humanOnly = human studies not also tagged animal, animalOnly = animal studies not tagged human, rct = human randomised trials. They count papers mentioning the topic, not positive results.
A double-blind placebo-controlled trial of DSIP in people with severe chronic insomnia found that daytime alertness and performance rose, so it concerns people with sleep loss, not healthy focus.[5]
In rats, Selank improved object recognition memory and prevented ethanol-linked memory and attention disturbances, an animal-only result.[6]
Common questions
Explore nearby goals
Sources
- 1[The efficacy of semax in the tretament of patients at different stages of ischemic stroke].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2018PMID 29798983Accessed 2 Oct 2026
- 2[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014PMID 25176261Accessed 2 Oct 2026
- 3Official web pageOfficial web page · web page
- 4Official web pageOfficial web page · web page
- 5Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia.European neurology · 1987PMID 3622582Accessed 2 Oct 2026
- 6Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.Bulletin of experimental biology and medicine · 2019PMID 31625062Accessed 2 Oct 2026
Found an error? Report a correction.